Skip to Content
Merck
HomeWebinarsGetting Started in 3D Cell Culture and 3D Bioprinting

Getting Started in 3D Cell Culture and 3D Bioprinting



WEBINAR

What will you learn?

  • Discover which factors you need to consider when making the switch from 2D to 3D cell culture. You will also get a good overview of what tools Merck have available for 3D cell culture.
  • You will get an introduction to different bioprinting methods and application areas. You will also get some guidance on what materials, bioinks, and tools you need to succeed in 3D bioprinting.

Cultivate Reality: Cell Culture in 3D Systems

It is well-published by the scientific community that cells cultured in 3D environments, in many cases, better recapitulate the in vivo environment and behaviors of cells. However, it is not a trivial change to move from 2D cell culture conditions to 3D, and not always easy to choose the right system to use. Understanding the key parameters for 2D and 3D cell culture is essential for choosing the appropriate system for the application.

Getting Started in 3D Bioprinting

3D bioprinting is the layer-by-layer printing of living cells, biomaterials, and extracellular matrix components to fabricate 3D tissue constructs in order to precisely mimic or replace native tissue. 3D bioprinting has the potential to solve many critical unmet needs in medical research, with applications in drug discovery, regenerative medicine, and the potential replacement of functional organs and animal-based testing methods. Merck has developed ready-to-use 3D printing bioinks that support the growth of living cells. Our bioinks mimic the extracellular matrix environment and promote cell adhesion, proliferation, and differentiation after printing.

Speakers

Dr. Cornelia Roessler

Dr. Cornelia Roessler

Merck

Ph.D.

Following her doctoral thesis at the Institute of Biochemistry in Frankfurt, Dr. Cornelia Roessler started her professional experience at Chemicon International. After several acquisitions and now more than 20 years of experience in the cell culture area she is working as a Technology Manager at Merck managing the entire cell culture portfolio for Western Europe.

Dr. Adelina Braun

Dr. Adelina Braun

Merck

Ph.D.

Dr. Adelina Braun completed her doctorate thesis in Materials Science at Saarland University, Germany. She then gained professional experience at the European Commission’s Joint Research Centre working on nanomaterials research projects. Adelina joined the Life Science Business at Merck 8 years ago and manages the Materials Science portfolio for all of Western Europe.

Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?